NEU 6.41% $15.27 neuren pharmaceuticals limited

TROFINETIDE PRIORITY REVIEW IN CANADA, page-2

  1. 88 Posts.
    lightbulb Created with Sketch. 1
    ✔ review within 180 days, approval before EOY maybe?



 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.